283 related articles for article (PubMed ID: 9214604)
1. Genetic polymorphism of CYP2D6 and lung cancer risk in African-Americans and Caucasians in Los Angeles County.
London SJ; Daly AK; Leathart JB; Navidi WC; Carpenter CC; Idle JR
Carcinogenesis; 1997 Jun; 18(6):1203-14. PubMed ID: 9214604
[TBL] [Abstract][Full Text] [Related]
2. Lung cancer risk in relation to the CYP2C9*1/CYP2C9*2 genetic polymorphism among African-Americans and Caucasians in Los Angeles County, California.
London SJ; Daly AK; Leathart JB; Navidi WC; Idle JR
Pharmacogenetics; 1996 Dec; 6(6):527-33. PubMed ID: 9014202
[TBL] [Abstract][Full Text] [Related]
3. Polymorphism of glutathione S-transferase M1 and lung cancer risk among African-Americans and Caucasians in Los Angeles County, California.
London SJ; Daly AK; Cooper J; Navidi WC; Carpenter CL; Idle JR
J Natl Cancer Inst; 1995 Aug; 87(16):1246-53. PubMed ID: 7563171
[TBL] [Abstract][Full Text] [Related]
4. Lung cancer risk in relation to the CYP2E1 Rsa I genetic polymorphism among African-Americans and Caucasians in Los Angeles County.
London SJ; Daly AK; Cooper J; Carpenter CL; Navidi WC; Ding L; Idle JR
Pharmacogenetics; 1996 Apr; 6(2):151-8. PubMed ID: 9156693
[TBL] [Abstract][Full Text] [Related]
5. Re: London,S.J. et al. (1997) Genetic polymorphism of CYP2D6 and lung cancer risk in African-Americans and Caucasians in Los Angeles County. Carcinogenesis, 18, 1203-1214.
Bouchardy C; Benhamou S; Dayer P
Carcinogenesis; 1998 Mar; 19(3):533-5. PubMed ID: 9525292
[No Abstract] [Full Text] [Related]
6. CYP2D6 phenotype-genotype relationships in African-Americans and Caucasians in Los Angeles.
Leathart JB; London SJ; Steward A; Adams JD; Idle JR; Daly AK
Pharmacogenetics; 1998 Dec; 8(6):529-41. PubMed ID: 9918137
[TBL] [Abstract][Full Text] [Related]
7. Genetic polymorphism of XRCC1 and lung cancer risk among African-Americans and Caucasians.
David-Beabes GL; London SJ
Lung Cancer; 2001 Dec; 34(3):333-9. PubMed ID: 11714530
[TBL] [Abstract][Full Text] [Related]
8. Lung cancer risk in relation to genetic polymorphisms of microsomal epoxide hydrolase among African-Americans and Caucasians in Los Angeles County.
London SJ; Smart J; Daly AK
Lung Cancer; 2000 May; 28(2):147-55. PubMed ID: 10717332
[TBL] [Abstract][Full Text] [Related]
9. Cytochrome P450 CYP2D6 gene polymorphism and lung cancer susceptibility in Caucasians.
Legrand-Andréoletti M; Stücker I; Marez D; Galais P; Cosme J; Sabbagh N; Spire C; Cenée S; Lafitte JJ; Beaune P; Broly F
Pharmacogenetics; 1998 Feb; 8(1):7-14. PubMed ID: 9511176
[TBL] [Abstract][Full Text] [Related]
10. Frequency of the variant allele CYP2D6(C) among North American Caucasian lung cancer patients and controls.
Shaw GL; Weiffenbach B; Falk RT; Frame JN; Issaq HJ; Moir DT; Caporaso N
Lung Cancer; 1997 May; 17(1):61-8. PubMed ID: 9194027
[TBL] [Abstract][Full Text] [Related]
11. Functionally active duplications of the CYP2D6 gene are more prevalent among larynx and lung cancer patients.
Agúndez JA; Gallardo L; Ledesma MC; Lozano L; Rodriguez-Lescure A; Pontes JC; Iglesias-Moreno MC; Poch J; Ladero JM; Benítez J
Oncology; 2001; 61(1):59-63. PubMed ID: 11474250
[TBL] [Abstract][Full Text] [Related]
12. Dietary isothiocyanates, glutathione S-transferase M1 (GSTM1), and lung cancer risk in African Americans and Caucasians from Los Angeles County, California.
Carpenter CL; Yu MC; London SJ
Nutr Cancer; 2009; 61(4):492-9. PubMed ID: 19838921
[TBL] [Abstract][Full Text] [Related]
13. CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants.
Bradford LD
Pharmacogenomics; 2002 Mar; 3(2):229-43. PubMed ID: 11972444
[TBL] [Abstract][Full Text] [Related]
14. The CYP2D6 activity score: translating genotype information into a qualitative measure of phenotype.
Gaedigk A; Simon SD; Pearce RE; Bradford LD; Kennedy MJ; Leeder JS
Clin Pharmacol Ther; 2008 Feb; 83(2):234-42. PubMed ID: 17971818
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the CYP2D6 gene polymorphism and enzyme activity in African-Americans in southern California.
Wan YJ; Poland RE; Han G; Konishi T; Zheng YP; Berman N; Lin KM
Pharmacogenetics; 2001 Aug; 11(6):489-99. PubMed ID: 11505219
[TBL] [Abstract][Full Text] [Related]
16. CYP2D6 genotype and the incidence of anal and vulvar cancer.
Chen C; Cook LS; Li XY; Hallagan S; Madeleine MM; Daling JR; Weiss NS
Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):317-21. PubMed ID: 10207635
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphism of CYP2D6 and lung cancer risk.
Shaw GL; Falk RT; Frame JN; Weiffenbach B; Nesbitt JC; Pass HI; Caporaso NE; Moir DT; Tucker MA
Cancer Epidemiol Biomarkers Prev; 1998 Mar; 7(3):215-9. PubMed ID: 9521436
[TBL] [Abstract][Full Text] [Related]
18. Deletion polymorphism of UDP-glucuronosyltransferase 2B17 and risk of prostate cancer in African American and Caucasian men.
Park J; Chen L; Ratnashinge L; Sellers TA; Tanner JP; Lee JH; Dossett N; Lang N; Kadlubar FF; Ambrosone CB; Zachariah B; Heysek RV; Patterson S; Pow-Sang J
Cancer Epidemiol Biomarkers Prev; 2006 Aug; 15(8):1473-8. PubMed ID: 16896035
[TBL] [Abstract][Full Text] [Related]
19. Analysis of cytochrome P450 2E1 genetic polymorphisms in relation to human lung cancer.
Kato S; Shields PG; Caporaso NE; Sugimura H; Trivers GE; Tucker MA; Trump BF; Weston A; Harris CC
Cancer Epidemiol Biomarkers Prev; 1994 Sep; 3(6):515-8. PubMed ID: 8000304
[TBL] [Abstract][Full Text] [Related]
20. CYP1A1 and CYP1B1 polymorphisms and risk of lung cancer among never smokers: a population-based study.
Wenzlaff AS; Cote ML; Bock CH; Land SJ; Santer SK; Schwartz DR; Schwartz AG
Carcinogenesis; 2005 Dec; 26(12):2207-12. PubMed ID: 16051642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
